Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00323
|
|||||
Drug Name |
Budesonide
|
|||||
Synonyms |
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione; (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione; (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one; (R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde; (RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione; (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde; (S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione; 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione; 16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione; 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione; 16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; 16alpha-,17alpha-butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione; B 7777; Bidien; Budecort Inhaler; Budenofalk; Budeson; Budesonide (JAN/USAN/INN);Budesonide [USAN:INN:BAN:JAN]; Budesonide Easyhaler; Budesonide MMX; Budesonido; Budesonido [INN-Spanish]; Budesonidum; Budesonidum [INN-Latin]; Budiair; Cortivent; Dexbudesonide; Dexbudesonide [INN]; Entocort; Entocort (TN); Entocort EC; Entocort EC (TN); GionaEasyhaler; Horacort; Inflammide; MAP-0010; Micronyl; Miflonide; Noex (TN); Preferid; Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-,and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione; Pulmaxan; Pulmaxan turbohaler; Pulmicort; Pulmicort (TN); Pulmicort Flexhaler; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Topinasal; Pulmicort turbuhaler; Respules; Rhinocort; Rhinocort (TN); Rhinocort Aqua; Rhinocort Turbuhaler; Rhinocort alpha; Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide; S 1320; S-1320; Spirocort; UDB; Unit dosebudesonide
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antiinflammatory Agents
|
|||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C25H34O6
|
|||||
Canonical SMILES |
CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C
|
|||||
InChI |
InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
|
|||||
InChIKey |
VOVIALXJUBGFJZ-KWVAZRHASA-N
|
|||||
CAS Number |
CAS 51333-22-3
|
|||||
Pharmaceutical Properties | Molecular Weight | 430.5 | Topological Polar Surface Area | 93.1 | ||
Heavy Atom Count | 31 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
2.5
|
|||||
PubChem CID | ||||||
PubChem SID |
10321783
,103455384
,103914268
,104170124
,11466546
,11467666
,11486132
,11528595
,12013315
,121360873
,121362487
,121363112
,124749512
,124800069
,124886759
,126627527
,126651544
,127278596
,127278597
,14807548
,14929955
,17404737
,24278277
,39289945
,46504869
,47646553
,47720602
,47869643
,47943751
,48169361
,49698535
,50105232
,53777280
,53789711
,56394980
,56422168
,57357962
,77787022
,7847312
,7978823
,81092787
,855541
,85787937
,8616471
,90341081
,90473637
,92125441
,92303636
,92721807
,93576669
|
|||||
ChEBI ID |
ChEBI:3207
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.